United States
Germany
Japan
United Kingdom
China
Human IgG (H&L) Antibody Alkaline Phosphatase Conjugated
| Applications | WB: 1:500 - 1:2,500 IHC: 1:200 - 1:1,000 ELISA: 1:2,000 - 1:10,000 |
| Reactivities | Human |
| Conjugation | Alkaline Phosphatase |
Products
IKB alpha (NFKBIA) sheep polyclonal antibody, Purified
| Applications | ELISA, EMSA, IP, WB |
| Reactivities | Human |
Human IgA (Secretory component, free and bound) sheep polyclonal antibody, HRP
| Applications | This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
| Reactivities | Human |
| Conjugation | HRP |
TA355211 is a possible alternative to AP21476HR-N.
PF4 sheep polyclonal antibody, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
p53 (TP53) sheep polyclonal antibody, Purified
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Orexin (HCRT) (2-14) sheep polyclonal antibody, Ig Fraction
| Applications | ELISA, IHC |
| Reactivities | Human, Bovine, Canine, Equine, Porcine, Rabbit, Monkey, Rat |
Human IgA (Fc specific) sheep polyclonal antibody, TRITC
| Applications | Direct staining of fixed cell and tissue substrates, to demonstrate the intracellular presence of IgA. The absence of the Fc domain in the conjugate ensures minimal interaction with the tissue components and cell surfaces other than the primary antibody activity. This conjugate is primarily intended for use in cell surface membrane staining procedures, to identify and quantitate Ig on B cells, especially if interference by Fc activity is expected. Recommended Dilutions: 1/10-1/40 This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
| Reactivities | Human |
| Conjugation | TRITC |
Human IgG (Fc specific) sheep polyclonal antibody, TRITC
| Applications | Direct staining of fixed cell and tissue substrates, to demonstrate the intracellular presence of IgG. The absence of the Fc domain in the conjugate ensures minimal interaction with the tissue components and cell surfaces other than the primary antibody activity. This conjugate is primarily intended for use in cell surface membrane staining procedures, to identify and quantitate Ig on B cells, especially if interference by Fc activity is expected. Recommended Dilutions: 1/10-1/40 This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
| Reactivities | Human |
| Conjugation | TRITC |
LEF1 sheep polyclonal antibody, Purified
| Applications | WB |
| Reactivities | Human |
Prostate Specific Antigen (KLK3) sheep polyclonal antibody, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
DYRK sheep polyclonal antibody, Purified
| Applications | IP, WB |
| Reactivities | Human, Mouse, Rat |
Decorin (DCN) (6-19) sheep polyclonal antibody, Purified
| Applications | ELISA, IHC |
| Reactivities | Bovine, Chicken, Human |
VAV2 (SHD Region) sheep polyclonal antibody, Purified
| Applications | IP, WB |
| Reactivities | Human |
PPP2R1B sheep polyclonal antibody, Purified
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Target Symbol
- NPPA (10)
- NPPC (6)
- ALB (3)
- DEFB4A (3)
- EPH RECEPTOR B1 (3)
- GOX (3)
- CALCA (2)
- DOPAMINE BETA HYDROXYLASE (2)
- HCRT (2)
- IDO1 (2)
- INSULIN (2)
- MAGI3 (2)
- PP1C GAMMA (2)
- PP2A-ALPHA (2)
- PTHLH (2)
- TF (2)
- THYMIDYLATE SYNTHASE (2)
- VAV2 (2)
- VWA2 (2)
- VWF (2)
- A2M (1)
- ACP1 (1)
- AKT1 (1)
- AMBP (1)
- AMY1C (1)
- AMY2A (1)
- ATM (1)
- BCL2 (1)
- BCL2L1 (1)
- C1QA (1)
- C3 (1)
- CA2 (1)
- CALCINEURIN A (1)
- CALR (1)
- CHEK1 (1)
- CHGA (1)
- COMPLEMENT C3 (1)
- CP (1)
- CYCS (1)
- DCN (1)
- DNM1 (1)
- ERBB2 (1)
- F12 (1)
- FACTOR IX (1)
- FACTOR VIII (1)
- FLI1 (1)
- GAP43 (1)
- GH1 (1)
- GLP1 (1)
- HP (1)
- INTERFERON BETA (1)
- KLK3 (1)
- LEF1 (1)
- LMO2 (1)
- LPA (1)
- LYSOZYME (1)
- MARK3 (1)
- MDH1 (1)
- MTGR1 (1)
- NFKBIA (1)
- NPY1R (1)
- PF4 (1)
- PPP1CA (1)
- PPP1CB (1)
- PPP2R1A (1)
- PPP2R1B (1)
- PPP4C (1)
- PPP6C (1)
- S100A7 (1)
- TH (1)
- TP53 (1)
- TPH1 (1)
- TRYPTOPHAN HYDROXYLASE (1)
- TYMS (1)
- TYROSINE HYDROXYLASE (1)
- VAMP1 (1)
Applications
Modifications
Clonalities
Assay Types
Families
Pathways
- Oocyte meiosis (9)
- Tight junction (7)
- Metabolic pathways (6)
- Insulin signaling pathway (5)
- Wnt signaling pathway (5)
- Axon guidance (4)
- Long-term depression (4)
- Regulation of actin cytoskeleton (4)
- TGF-beta signaling pathway (4)
- Apoptosis (3)
- Complement and coagulation cascades (3)
- Focal adhesion (3)
- Long-term potentiation (3)
- Progesterone-mediated oocyte maturation (3)
- Prostate cancer (3)
- Tyrosine metabolism (3)
- mTOR signaling pathway (3)
- B cell receptor signaling pathway (2)
- Chemokine signaling pathway (2)
- Cytokine-cytokine receptor interaction (2)
- Jak-STAT signaling pathway (2)
- MAPK signaling pathway (2)
- Maturity onset diabetes of the young (2)
- Natural killer cell mediated cytotoxicity (2)
- One carbon pool by folate (2)
- Pyrimidine metabolism (2)
- Regulation of autophagy (2)
- T cell receptor signaling pathway (2)
- Toll-like receptor signaling pathway (2)
- Type I diabetes mellitus (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
- Acute myeloid leukemia (1)
- Adipocytokine signaling pathway (1)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Calcium signaling pathway (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Cytosolic DNA-sensing pathway (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Fc epsilon RI signaling pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- Glioma (1)
- Melanoma (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Pancreatic cancer (1)
- Parkinson's disease (1)
- Pathways in cancer (1)
- RIG-I-like receptor signaling pathway (1)
- Renal cell carcinoma (1)
- Small cell lung cancer (1)
- Systemic lupus erythematosus (1)
- Tryptophan metabolism (1)
- p53 signaling pathway (1)
